Document:

Trademark Assignment, dated as of January 1, 2006

 Exhibit 10.37 
 TRADEMARK ASSIGNMENT 
 THIS ASSIGNMENT OF TRADEMARKS (this “Assignment”) is made as of the
1st day of January, 2006, by and among Westwood-Squibb Pharmaceuticals, Inc. (“Assignor”), a subsidiary of
Bristol-Myers Squibb Company, a Delaware corporation (“Seller”), Warner Chilcott Company, Inc., a Puerto Rican corporation (“WCCI”) and LEO Pharma A/S, a Danish entity (“Assignee”). 
 W I T N E S S E T H 
 WHEREAS, Seller is engaged in distributing, marketing and selling products under the trademark Dovonex® (the “Product”); and

 WHEREAS, Seller and WCCI have entered into an Asset Purchase Agreement for products under the trademark Dovonex® dated as of the 30th
day of September, 2005 (the “Asset Purchase Agreement”), pursuant to which Seller is selling or causing to be sold to WCCI, and WCCI is purchasing and acquiring, among other things, certain assets connected with the Product, including
right, title, and interest in and to those names and marks in the Territory (as such term is defined in the Asset Purchase Agreement), including the registrations and/or applications set forth on such Schedule I annexed hereto (collectively, the
“Trademark”); 
 WHEREAS, WCCI and Assignee (i) represent and warrant to Seller that (A) they have entered into a Master
Agreement dated as of April 1, 2003, as amended (the “Master Agreement”), pursuant to which WCCI has agreed to transfer to Assignee (upon acquisition from Seller), in consideration of the rights granted to WCCI therein, title
and interest in the Trademark, and (B) such Master Agreement remains in force and effect and will remain in force and effect through the date of the Closing (as defined in the Asset Purchase Agreement); 
 WHEREAS, in satisfaction of WCCI’s obligations under the Master Agreement, WCCI and Assignee have requested that Seller cause Assignor to assign its
right, title and interest in and to the Trademark to the Assignee, as designee of WCCI, and Seller is willing to do same. 
 NOW, THEREFORE,
in consideration of the foregoing representations and warranties and for good and valuable consideration the sufficiency of which are hereby acknowledged, Assignor does hereby sell, assign, transfer, set over, and deliver to Assignee all right,
title and interest in and to: 
  

	 	(i)	the Trademark; 

  

	 	(ii)	the goodwill of Seller’s and Assignor’s business connected with the use of the Trademark; 

  

	 	(iii)	all rights of enforcement and the right to damages for past infringement, unfair competition or other conflicts relating to the Trademark; and 

  

	 	(iv)	except as limited hereto and by the Asset Purchase Agreement, all other rights, including common law rights, relating to the Trademark in the Territory to the extent such rights
exist. 

 FURTHERMORE, Assignor will, at the expense of Assignee, (i) execute and deliver such further instruments
including, without limitation, further instruments of assignment, and (ii) take such further actions as Assignee may reasonably request in order to register this Assignment at the appropriate registries and to demonstrate Assignee’s title
to the Trademark or in order to prosecute any of the pending applications included in the Trademark. 
 FURTHERMORE, for avoidance of doubt,
WCCI and Assignee acknowledge and agree that Seller and Assignor make no representations or warranties whatsoever with respect to the Trademark and the other assets and rights described in clauses (ii), (iii) and (iv) above (including any
representations and warranties with respect to the existence, validity, enforceability, use or ownership of any such common law rights), except for those representations and warranties expressly set forth in Section 2.07 of the Asset Purchase
Agreement. 
 FURTHERMORE, WCCI shall be and remain solely responsible for any and all consideration due Seller, and for the assumption of
liabilities from Seller, under and in accordance with the Asset Purchase Agreement, the Option Agreement and/or the Definitive Agreements, notwithstanding the assignment by Assignor to LEO of the Trademark as herein provided. 
 This Assignment shall be governed by and construed in accordance with the laws of the State of New York, without regard to any applicable principles of
conflicts of law, other than Section 5-1401 of the New York General Obligations Law. Each of the Parties hereto hereby irrevocably and unconditionally consents to jurisdiction as set forth in Section 8.12 of the Asset Purchase Agreement.
All capitalized terms not defined herein shall have the meaning ascribed to such term in the Asset Purchase Agreement 
 IN WITNESS WHEREOF,
the Parties hereto have executed this Assignment of Trademarks for Dovonex® as of the date first written above. 
  

 2 

			
	 WESTWOOD-SQUIBB
 PHARMACEUTICALS,
INC.

		
	By:	 	 /s/ Tamar D. Howson

	Name:	 	Tamar D. Howson
	Title:	 	Senior Vice President, Corporate Development
	
	WARNER CHILCOTT COMPANY, INC.
		
	By:	 	 /s/ Anthony D. Bruno

	Name:	 	Anthony D. Bruno
	Title:	 	Executive Vice President
	
	LEO PHARMA A/S
		
	By:	 	 /s/ Ernst Lunding

	Name:	 	Enrst Lunding
	Title:	 	President, CEO

  

 3 

 SCHEDULE I 
 U.S. Trademark for Dovonex® 
 Registration Number – 1799033 
 Serial Number – 74124643 
 Registered – October 19, 1993 
 Registered Owner - Westwood-Squibb Pharmaceuticals, Inc. 
  

 4Amendment, dated as of March 29, 2005, to the Credit Agreement

 Exhibit 10.38 
 EXECUTION COPY 
 AMENDMENT dated as of March 29, 2005 (this “Amendment”), to the
Credit Agreement dated as of January 18, 2005 (the “Credit Agreement”), among WARNER CHILCOTT HOLDINGS COMPANY III, LIMITED, a company organized under the laws of Bermuda (the “BR Borrower”), WARNER
CHILCOTT CORPORATION, a Delaware corporation (the “US Borrower”), WARNER CHILCOTT COMPANY, INC., a corporation organized under the laws of Puerto Rico (the “PR Borrower”, and together with the
BR Borrower and the US Borrower, the “Borrowers”), the Lenders (as defined in the introductory paragraph to the Credit Agreement), and CREDIT SUISSE FIRST BOSTON, as administrative agent (in such capacity, the
“Administrative Agent”). 
 A. Pursuant to the Credit Agreement, the Lenders have extended, and have agreed to extend,
credit to the Borrowers. 
 B. The Borrowers have requested certain amendments to the Credit Agreement as set forth herein. 
 C. Capitalized terms used but not defined herein shall have the meanings assigned to them in the Credit Agreement. 
 Accordingly, in consideration of the mutual agreements herein contained and other good and valuable consideration, the sufficiency and receipt of which
are hereby acknowledged, the parties hereto agree as follows: 
 SECTION 1. Amendments to Credit Agreement. (a) The definition of
the term “Hedge Bank” set forth in Section 1.01 of the Credit Agreement is hereby amended by adding the words “, an Agent or an Arranger” immediately following the word “Lender” in each place such word
appears in such definition. 
 (b) The definition of the term “Obligations” set forth in Section 1.01 of the Credit
Agreement is hereby amended and restated in its entirety to read as follows: 
 “Obligations” means
(a) for purposes of this Agreement, all advances to, and debts, liabilities, obligations, covenants and duties of, any Loan Party arising under any Loan Document or otherwise with respect to any Loan or Letter of Credit, whether direct or
indirect (including those acquired by assumption), absolute or contingent, due or to become due, now existing or hereafter arising and including interest and fees that accrue after the commencement by or against any Loan Party of any proceeding
under any Debtor Relief Laws naming such Person as the debtor in such proceeding, regardless of whether such interest and fees are allowed claims in such proceeding and (b) for purposes of the Collateral Documents and each Guaranty,
(x) all “Obligations” as defined in the foregoing clause (a), (y) all Secured Hedge Obligations and (z) all Cash Management Obligations. Without limiting the generality of the foregoing, the Obligations of the Loan Parties
under the Loan Documents include (a) the obligation to pay principal, interest, Letter of Credit commissions, charges, expenses, fees, Attorney Costs, indemnities and other amounts payable by any Loan Party under any Loan Document and
(b) the obligation of any Loan Party to reimburse any 

 
amount in respect of any of the foregoing that any Lender, in its sole discretion, may elect to pay or advance on behalf of such Loan Party. 
 (c) The definition of the term “Secured Hedge Obligations” set forth in Section 1.01 of the Credit Agreement is hereby amended and
restated in its entirety to read as follows: 
 “Secured Hedge Obligations” means the obligations of any Loan
Party arising under any Secured Hedge Agreement. 
 SECTION 2. Representations and Warranties. To induce the other parties hereto to
enter into this Amendment, the Borrowers represent and warrant to each of the Lenders and the Administrative Agent that, after giving effect to this Amendment, (a) the representations and warranties set forth in Article V of the Credit
Agreement are true and correct in all material respects on and as of the date hereof, except to the extent such representations and warranties expressly relate to an earlier date, in which case they are true and correct in all material respects as
of such earlier date, and (b) no Default or Event of Default has occurred and is continuing. 
 SECTION 3. Effectiveness of
Amendment. This Amendment shall become effective as of the date set forth above on the date on which the Administrative Agent (or its counsel) shall have received counterparts of this Amendment that, when taken together, bear the signatures of
the Borrowers, the Guarantors and the Required Lenders. 
 SECTION 4. Effect of Amendment. Except as expressly set forth herein, this
Amendment shall not by implication or otherwise limit, impair, constitute a waiver of, or otherwise affect the rights and remedies of the Lenders or the Administrative Agent under the Credit Agreement or any other Loan Document, and shall not alter,
modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other Loan Document, all of which are ratified and affirmed in all respects and shall continue in full
force and effect. Nothing herein shall be deemed to entitle any Loan Party to a consent to, or a waiver, amendment, modification or other change of, any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement
or any other Loan Document in similar or different circumstances. This Amendment shall apply and be effective only with respect to the provisions of the Credit Agreement specifically referred to herein. After the date hereof, any reference to the
Credit Agreement shall mean the Credit Agreement as modified hereby. This Amendment shall constitute a “Loan Document” for all purposes of the Credit Agreement and the other Loan Documents. 
 SECTION 5. Counterparts. This Amendment may be executed in one or more counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument. Delivery by telecopier or electronic mail of an executed counterpart of a signature page to this Amendment shall be effective as delivery of an original executed counterpart of this Amendment.
The Administrative Agent may also require that any such signature page delivered by telecopier or electronic mail be confirmed by a manually signed original thereof; provided that the failure to request or 

  

 2 

 
deliver the same shall not limit the effectiveness of any signature page delivered by telecopier or electronic mail. 
 SECTION 6. Governing Law. THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.

 SECTION 7. Headings. Section headings herein are included for convenience of reference only and shall not affect the interpretation
of this Amendment. 
 SECTION 8. Acknowledgment of Guarantors. Each of the Guarantors hereby acknowledges receipt and notice of, and
consents to the terms of, this Amendment. 
 [THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK AND 
 THE SIGNATURE PAGES HAVE BEEN OMITTED.] 
  

 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}]]